home / scout

EV-surface aptamer targets — membrane-surface vs cargo, ranked (view)

PREDICTED EV-surface accessibility (not a measurement). EV biogenesis normally preserves membrane topology, so we predict which targets present an extracellular epitope on an INTACT vesicle. surface_class A_surface = integral/ecto cell-surface (CD/GPCR/ion-channel/integral membrane). A2_pm_peripheral = plasma-membrane but cytoplasmic-leaflet (SRC/LYN/RHOA/FLNA) — predicted NOT reachable. A_assoc = secreted / surface-corona. CAVEATS: HPA gives cellular (not EV) localization; lipid asymmetry can partially flip (phosphatidylserine externalizes via scramblase TMEM16F on activated/platelet/apoptotic EVs); cytoplasmic proteins can attach as a protein corona; EV populations are heterogeneous. CONFIRM by protease-protection (proteinase K +/- detergent), intact-EV surface labelling / bead-capture flow, or immuno-EM. Classification from HPA subcellular localization + protein class (Thul 2017; Uhlén 2015). targetability_score is a transparent composite, not experimental.

Data license: CC BY 4.0 · Data source: apt-scout automated curation pipeline (E. Dohi, NCNP) — values harvested from public databases; raw source stored per target

surface_class
PREDICTED topology: A_surface (ecto, predicted accessible) / A2_pm_peripheral (cytoplasmic leaflet, predicted not accessible) / A_assoc (secreted/corona). Confirm experimentally.
surface_evidence
Which HPA field drove the call (no fabrication).
ev_map_hallmark
1 = EV-Map conserved EV-hallmark protein (Rai & Greening 2025) — strongest evidence it is on circulating EVs.
targetability_score
Composite: 1.0[integral surface] + 0.8[EV-Map hallmark] + 0.3[in EV proteome] + 0.4[has PDB] + 0.3 min(disease,1) + 0.2[approved drug]. Heuristic, NOT experimental.
pdb_count
Experimental PDB structures available to design against.
disease_score
Open Targets top disease association score.

303 rows where ev_map_hallmark = 0, in_cev_map = 0 and surface_class = "A_assoc" sorted by targetability_score descending

✎ View and edit SQL

This data as json, CSV (advanced)

Suggested facets: surface_evidence

surface_class 1

  • A_assoc · 303 ✖

in_cev_map 1

  • - · 303 ✖

ev_map_hallmark 1

  • - · 303 ✖
id gene_symbol protein_name surface_class surface_evidence ev_map_hallmark in_cev_map in_vesiclepedia in_exocarta pdb_count top_disease disease_score drug_count_approved targetability_score ▲
Q00604 NDP Norrin A_assoc HPA Predicted secreted (soluble; may form EV surface corona, not integral) 0 0     11 Norrie disease 0.8566451682188412   0.657
P15884 TCF4 Transcription factor 4 A_assoc HPA Predicted secreted (soluble; may form EV surface corona, not integral) 0 0     5 Pitt-Hopkins syndrome 0.8490531860867685   0.655
Q9NZK5 ADA2 Adenosine deaminase 2 A_assoc HPA Predicted secreted (soluble; may form EV surface corona, not integral) 0 0     2 deficiency of adenosine deaminase 2 0.8291292532404531   0.649
Q99972 MYOC Myocilin A_assoc HPA Predicted secreted (soluble; may form EV surface corona, not integral) 0 0     24 glaucoma 1, open angle, A 0.8294483747483756   0.649
O95970 LGI1 Leucine-rich glioma-inactivated protein 1 A_assoc HPA Predicted secreted (soluble; may form EV surface corona, not integral) 0 0     9 autosomal dominant epilepsy with auditory features 0.8225657483127345   0.647
Q9UBH0 IL36RN Interleukin-36 receptor antagonist protein A_assoc HPA Predicted secreted (soluble; may form EV surface corona, not integral) 0 0     3 psoriasis 14, pustular 0.8155144873787125   0.645
P20062 TCN2 Transcobalamin-2 A_assoc HPA Predicted secreted (soluble; may form EV surface corona, not integral) 0 0     11 transcobalamin II deficiency 0.8116989428679681   0.644
Q96MK3 FAM20A Pseudokinase FAM20A A_assoc HPA Predicted secreted (soluble; may form EV surface corona, not integral) 0 0     4 amelogenesis imperfecta type 1G 0.8106031517056754   0.643
P55000 SLURP1 Secreted Ly-6/uPAR-related protein 1 A_assoc HPA Predicted secreted (soluble; may form EV surface corona, not integral) 0 0     2 mal de Meleda 0.8064330379723671   0.642
P45452 MMP13 Collagenase 3 A_assoc HPA Predicted secreted (soluble; may form EV surface corona, not integral) 0 0     49 spondyloepimetaphyseal dysplasia, Missouri type 0.8032079813035149   0.641
P29460 IL12B Interleukin-12 subunit beta A_assoc HPA Predicted secreted (soluble; may form EV surface corona, not integral) 0 0     20 psoriasis 0.7914863943708039   0.637
Q13253 NOG Noggin A_assoc HPA Predicted secreted (soluble; may form EV surface corona, not integral) 0 0     2 proximal symphalangism 1A 0.7844136456463046   0.635
P03971 AMH Anti-Muellerian hormone A_assoc HPA Predicted secreted (soluble; may form EV surface corona, not integral) 0 0     3 persistent Mullerian duct syndrome 0.7847328444470535   0.635
Q96S42 NODAL Nodal homolog A_assoc HPA Predicted secreted (soluble; may form EV surface corona, not integral) 0 0     1 heterotaxy, visceral, 5, autosomal 0.7788051667024423   0.634
P01138 NGF Beta-nerve growth factor A_assoc HPA Predicted secreted (soluble; may form EV surface corona, not integral) 0 0     8 hereditary sensory and autonomic neuropathy type 5 0.7785402119369383   0.634
P18510 IL1RN Interleukin-1 receptor antagonist protein A_assoc HPA Predicted secreted (soluble; may form EV surface corona, not integral) 0 0     5 sterile multifocal osteomyelitis with periostitis and pustulosis 0.7734282711738736   0.632
P29120 PCSK1 Neuroendocrine convertase 1 A_assoc HPA Predicted secreted (soluble; may form EV surface corona, not integral) 0 0     3 obesity due to prohormone convertase I deficiency 0.773875795833803   0.632
P00797 REN Renin A_assoc HPA Predicted secreted (soluble; may form EV surface corona, not integral) 0 0     91 familial juvenile hyperuricemic nephropathy type 2 0.7657976389758877   0.63
P05019 IGF1 Insulin-like growth factor 1 A_assoc HPA Predicted secreted (soluble; may form EV surface corona, not integral) 0 0     32 growth delay due to insulin-like growth factor type 1 deficiency 0.7650418939376437   0.63
Q9GZV9 FGF23 Fibroblast growth factor 23 A_assoc HPA Predicted secreted (soluble; may form EV surface corona, not integral) 0 0     6 autosomal dominant hypophosphatemic rickets 0.762326334964193   0.629
P20849 COL9A1 Collagen alpha-1(IX) chain A_assoc HPA Predicted secreted (soluble; may form EV surface corona, not integral) 0 0     5 Stickler syndrome 0.7594904923903256   0.628
P16112 ACAN Aggrecan core protein A_assoc HPA Predicted secreted (soluble; may form EV surface corona, not integral) 0 0     4 Familial osteochondritis dissecans 0.7558487616449627   0.627
P55789 GFER FAD-linked sulfhydryl oxidase ALR A_assoc HPA Predicted secreted (soluble; may form EV surface corona, not integral) 0 0     7 congenital cataract-progressive muscular hypotonia-hearing loss-developmental delay syndrome 0.7556346526616893   0.627
Q12794 HYAL1 Hyaluronidase-1 A_assoc HPA Predicted secreted (soluble; may form EV surface corona, not integral) 0 0     1 Hyaluronidase deficiency 0.7412407206736383   0.622
Q92752 TNR Tenascin-R A_assoc HPA Predicted secreted (soluble; may form EV surface corona, not integral) 0 0     2 neurodevelopmental disorder, nonprogressive, with spasticity and transient opisthotonus 0.7403484347367364   0.622
O15520 FGF10 Fibroblast growth factor 10 A_assoc HPA Predicted secreted (soluble; may form EV surface corona, not integral) 0 0     2 Lacrimoauriculodentodigital syndrome 0.7344198619465704   0.62
P35225 IL13 Interleukin-13 A_assoc HPA Predicted secreted (soluble; may form EV surface corona, not integral) 0 0     13 atopic eczema 0.7297489019498119   0.619
Q2MKA7 RSPO1 R-spondin-1 A_assoc HPA Predicted secreted (soluble; may form EV surface corona, not integral) 0 0     12 palmoplantar keratoderma-XX sex reversal-predisposition to squamous cell carcinoma syndrome 0.7285342885472184   0.619
Q9BQB4 SOST Sclerostin A_assoc HPA Predicted secreted (soluble; may form EV surface corona, not integral) 0 0     3 sclerosteosis 1 0.7184345506579789   0.616
P05305 EDN1 Endothelin-1 A_assoc HPA Predicted secreted (soluble; may form EV surface corona, not integral) 0 0     17 auriculocondylar syndrome 0.7193561828311311   0.616
P12272 PTHLH Parathyroid hormone-related protein A_assoc HPA Predicted secreted (soluble; may form EV surface corona, not integral) 0 0     11 brachydactyly type E 0.7203484375635054   0.616
O00300 TNFRSF11B Tumor necrosis factor receptor superfamily member 11B A_assoc HPA Predicted secreted (soluble; may form EV surface corona, not integral) 0 0     1 juvenile Paget disease 0.7184894548525037   0.616
Q99574 SERPINI1 Neuroserpin A_assoc HPA Predicted secreted (soluble; may form EV surface corona, not integral) 0 0     3 familial encephalopathy with neuroserpin inclusion bodies 0.7162803151916303   0.615
P01270 PTH Parathyroid hormone A_assoc HPA Predicted secreted (soluble; may form EV surface corona, not integral) 0 0     26 hypoparathyroidism, familial isolated 1 0.7147450451832739   0.614
P11686 SFTPC Surfactant protein C A_assoc HPA Predicted secreted (soluble; may form EV surface corona, not integral) 0 0     3 Congenital pulmonary alveolar proteinosis 0.7110128683619542   0.613
O43897 TLL1   A_assoc HPA Predicted secreted (soluble; may form EV surface corona, not integral) 0 0     1 atrial heart septal defect 0.7050140477090344   0.612
P19835 CEL Bile salt-activated lipase A_assoc HPA Predicted secreted (soluble; may form EV surface corona, not integral) 0 0     7 MODY 0.6940743944678538   0.608
O43323 DHH Desert hedgehog protein A_assoc HPA Predicted secreted (soluble; may form EV surface corona, not integral) 0 0     5 46,XY gonadal dysgenesis-motor and sensory neuropathy syndrome 0.6912706692651148   0.607
P27352 CBLIF Cobalamin binding intrinsic factor A_assoc HPA Predicted secreted (soluble; may form EV surface corona, not integral) 0 0     2 hereditary intrinsic factor deficiency 0.683930100359911   0.605
Q9Y5C1 ANGPTL3 Angiopoietin-related protein 3 A_assoc HPA Predicted secreted (soluble; may form EV surface corona, not integral) 0 0     1 familial hypobetalipoproteinemia 2 0.6739043862507132   0.602
Q9Y5K2 KLK4 Kallikrein-4 A_assoc HPA Predicted secreted (soluble; may form EV surface corona, not integral) 0 0     18 Hypomaturation amelogenesis imperfecta 0.6659029046455642   0.6
Q8N300 SVBP Small vasohibin-binding protein A_assoc HPA Predicted secreted (soluble; may form EV surface corona, not integral) 0 0     24 neurodevelopmental disorder with ataxia, hypotonia, and microcephaly 0.6640118055835142   0.599
O95631 NTN1 Netrin-1 A_assoc HPA Predicted secreted (soluble; may form EV surface corona, not integral) 0 0     5 mirror movements 4 0.6611393488240481   0.598
P05113 IL5 Interleukin-5 A_assoc HPA Predicted secreted (soluble; may form EV surface corona, not integral) 0 0     5 asthma 0.6399821251487101   0.592
Q16552 IL17A Interleukin-17A A_assoc HPA Predicted secreted (soluble; may form EV surface corona, not integral) 0 0     44 psoriasis 0.6367521314106471   0.591
O95390 GDF11 Growth/differentiation factor 11 A_assoc HPA Predicted secreted (soluble; may form EV surface corona, not integral) 0 0     5 vertebral hypersegmentation and orofacial anomalies 0.6207007733160915   0.586
P05230 FGF1 Fibroblast growth factor 1 A_assoc HPA Predicted secreted (soluble; may form EV surface corona, not integral) 0 0     96 cancer 0.6088477966360052   0.583
P22894 MMP8 Neutrophil collagenase A_assoc HPA Predicted secreted (soluble; may form EV surface corona, not integral) 0 0     25 acne 0.603247809982021   0.581
P09237 MMP7 Matrilysin A_assoc HPA Predicted secreted (soluble; may form EV surface corona, not integral) 0 0     16 acne 0.603247809982021   0.581
O76093 FGF18 Fibroblast growth factor 18 A_assoc HPA Predicted secreted (soluble; may form EV surface corona, not integral) 0 0     1 cancer 0.6028027301556572   0.581

Next page

Advanced export

JSON shape: default, array, newline-delimited

CSV options:

CREATE VIEW v_surface_targets AS
SELECT s.target_id AS id, n.gene_symbol, n.protein_name, s.surface_class, s.surface_evidence,
  e.cev_map_is_ev_hallmark AS ev_map_hallmark, e.in_cev_map, e.in_vesiclepedia, e.in_exocarta,
  l1.pdb_count_total AS pdb_count, l5.opentargets_top_disease_name AS top_disease,
  l5.opentargets_top_disease_score AS disease_score, l3.drug_count_approved,
  ROUND(
    (CASE WHEN s.surface_class='A_surface' THEN 1.0 ELSE 0 END)
    + 0.8*COALESCE(e.cev_map_is_ev_hallmark,0)
    + 0.3*(CASE WHEN COALESCE(e.in_cev_map,0)+COALESCE(e.in_vesiclepedia,0)+COALESCE(e.in_exocarta,0)>0 THEN 1 ELSE 0 END)
    + 0.4*(CASE WHEN CAST(COALESCE(l1.pdb_count_total,0) AS INTEGER)>0 THEN 1 ELSE 0 END)
    + 0.3*MIN(COALESCE(l5.opentargets_top_disease_score,0),1.0)
    + 0.2*(CASE WHEN CAST(COALESCE(l3.drug_count_approved,0) AS INTEGER)>0 THEN 1 ELSE 0 END)
  ,3) AS targetability_score
FROM membrane_surface_class s
LEFT JOIN target_names n ON n.target_id=s.target_id
LEFT JOIN target_layer4_expression e ON e.target_id=s.target_id
LEFT JOIN target_layer1_structure l1 ON l1.target_id=s.target_id
LEFT JOIN target_layer3_interaction l3 ON l3.target_id=s.target_id
LEFT JOIN target_layer5_disease l5 ON l5.target_id=s.target_id
WHERE s.surface_class IN ('A_surface','A2_pm_peripheral','A_assoc');
Powered by Datasette · Queries took 95.83ms · Data license: CC BY 4.0 · Data source: apt-scout automated curation pipeline (E. Dohi, NCNP) — values harvested from public databases; raw source stored per target